FDA Grants Breakthrough Status to Generative AI Chatbot for Surgical Patients
The Food and Drug Administration (FDA) has granted breakthrough device designation to a generative AI chatbot designed for patients recovering from joint replacement surgery. This marks a significant step in the FDA’s evolving stance on artificial intelligence in healthcare, particularly as it seeks to establish a regulatory framework for AI technologies. The designation comes at…









